Close
ACHEMA MIDDLE EAST 2026
5th LNP Formulation & Process Development Summit

Research & Development

New England Journal of Medicine publishes results of head-to-head studies of brodalumab versus ustekinumab in psoriasis

Research & Development
The New England Journal of Medicine (NEJM) has published positive results from two pivotal, multi-centre, Phase III studies –AMAGINE-2 and AMAGINE-3 – demonstrating that...

AstraZeneca and Lilly expand immuno-oncology research collaboration with new combinations

Research & Development
AstraZeneca and Eli Lilly and Company (Lilly) today announced an extension to their existing immuno-oncology collaboration exploring novel combination therapies for the treatment of...

Lilly To Discontinue Development Of Evacetrapib For High-Risk Atherosclerotic Cardiovascular Disease

Research & Development
Eli Lilly and Company (NYSE: LLY) and the ACCELERATE study's academic leadership have accepted the recommendation of the independent data monitoring committee to terminate...

Allergan and Humana Announce Research Partnership to Improve Health Outcomes

Research & Development
Allergan plc (NYSE: AGN), a leading global specialty pharmaceutical company, today announced a multi-year research collaboration with Humana Inc. (NYSE: HUM), one of the...

Research & development at sun pharma

Research & Development
We were pioneers among Indian pharmaceutical companies to see tremendous value in investing in research & development (R&D). Our early investments in R&D, beginning...

Strengthen return on investment through operational efficiency

Research & Development
In addition to ensuring that Amgen's investment decisions are based on compelling science, we are reengineering our processes to operate more efficiently. This ongoing...

Pursue a “Biology First” approach to choose the right targets and tools

Research & Development
At Amgen, we believe drug discovery starts with a deep understanding of biology. This understanding guides the critical choice of which disease target to...

Subscribe Our Newsletter

White Papers

The Future of Digital Health

Whitepapers 0
The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....

Five Best Practices to Deliver Exceptional Multichannel Experiences

Whitepapers 0
A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...

The Impact and Use of Social Media in Pharmacovigilance

Whitepapers 0
Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...

About us

Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and
comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector. . . Read More

Resources

Advertise

Subscribe

Copyright © Value Media Group 2026. All rights reserved.